Andree Blaukat

Andree Blaukat serves as CEO at Tessellate BIO. Tessellate BIO operates in the research sector with approximately 29.0 employees. The company is headquartered in Frankfurt, Hesse. Tessellate BIO generates annual revenue of 2100000.0. To date, Tessellate BIO has raised 8430560.0 in total funding, with the most recent round being Seed.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 763 executive contacts are available in Hesse.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 WordPress.org Google Font API Nginx Mobile Friendly Apache Android Circle

drug discovery precision oncology biotechnology biotechnology research synthetic lethality biomarker discovery companion diagnostics alt cancers lof program tumor suppressor retinoblastoma 1 rb1 alternative lengthening of telomeres cancer therapies small molecule drug discovery first-in-class medicines precision medicine drug development cancer patients unmet medical need tumor-targeted treatments clinical validation poly-adp-ribose polymerase parp inhibitors cancer genomics oncology research novel biology pipeline development target identification in vitro pharmacology therapeutic strategies dna damage response cancer cell death genomic stability telomere integrity personalized cancer therapy research collaborations scientific validation academic partnerships oncology drug discovery molecular diagnostics cancer metabolism kinase signaling genomic testing fda-approved tests tumor agnostic therapies early-stage biotechnology biopharmaceutical innovation life sciences partnerships

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Andree Blaukat in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Tessellate BIO.

Andree Blaukat's Position in the MessageCEO Database

• •Andree Blaukat is 1 of 1 verified executive contact we track at Tessellate BIO.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •757 verified executive contacts in Hesse are in the database.
• •43 verified contacts work at research companies in the 29.0 employee range (same size as Tessellate BIO).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Andree Blaukat directly?

Andree Blaukat's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Tessellate BIO. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Andree Blaukat work for?

Andree Blaukat is CEO at Tessellate BIO, a company in the research sector with 29.0 employees. The company is based in Frankfurt, Hesse.

Can I pitch or sell to Andree Blaukat?

As CEO at Tessellate BIO, Andree Blaukat is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Andree Blaukat directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Andree Blaukat in?

Andree Blaukat works in the research industry as CEO at Tessellate BIO. MessageCEO provides verified contact information for executives across all major industries.

Is Andree Blaukat's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Andree Blaukat's profile is kept up-to-date with the latest available information.

Last updated: June 24, 2026